Europe
Good safety profile and encouraging efficacy reported for recurrent glioblastoma patients with disrupted blood-brain barrier
The Lead Discovery Center and the Korean Drug Development Fund have entered into an agreement to facilitate the interaction between LDC and the prospering South Korean biotech scene.
3D co-cultured healthy cells survive in method for evaluation of TCR efficacy and toxicity
The American Association for Cancer Research (AACR) Annual Meeting is taking place in Atlanta. Here’s a look at just a few stories coming out of the meeting.
Dr. Sarah Fakih joined MorphoSys AG as Vice President and Head of Corporate Communications and Investor Relations effective April 1, 2019.
NOXXON Pharma N.V. announced the latest update of clinical results from the Phase 1/2 study of NOX-A12 in combination with Keytruda® in patients with microsatellite-stable, metastatic pancreatic and colorectal cancer in a poster presentation at the American Association for Cancer Research Annual Meeting.
Evotec SE announced that it has completed its conversion into a company under European law with its registration in the commercial register of the District Court of Hamburg.
IBBL is pleased to announce the positive results of its new Proficiency Testing programme in China.
While this type of personalized therapy is revolutionizing cancer treatment and healthcare, it has some formidable limitations.
The American Association for Cancer Research (AACR) Annual Meeting is ongoing in Atlanta, with plenty of companies presenting interesting and cutting-edge science. Here’s a look at just a representative few.
PRESS RELEASES